Kasurinen, A. et al. 2020. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer. Acta Oncologica. 59, 6 (Jun. 2020), 681–688. DOI:https://doi.org/10.1080/0284186X.2020.1733655.